Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814537 · ClinicalTrials.gov registry record · Phase 4
Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques
A Phase 4 study of Analgesia and Labor Pain, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04814537: Completed Phase 4 study of Analgesia and Labor Pain, sponsored by Brigham and Women's Hospital.
NCT04814537 is a Phase 4 study of Analgesia and Labor Pain that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 100 participants, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04814537, a Phase 4 study of Analgesia and Labor Pain, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
Primary Outcome
The dose of bupivacaine with which 90% of participants achieve adequate analgesia (NRS\<3 at 30min)
Conditions Studied
Interventions
- DRUG Bupivacaine Hydrochloride
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2022-03-23 |
| Phase | Phase 4 |
What the finished NCT04814537 record still lists
NCT04814537 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher).
The record links to 2 conditions, with Analgesia appearing as the primary indexed condition, and to 1 intervention - of which Bupivacaine Hydrochloride is the first listed.
NCT04814537 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04814537 about?
NCT04814537 is a clinical study titled "Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques". To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
What is the current status of trial NCT04814537?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2021-02-25. Estimated completion is 2022-03-23.
What conditions does trial NCT04814537 study?
This clinical trial studies the following conditions: Analgesia, Labor Pain.
What interventions are being tested in trial NCT04814537?
The interventions under investigation include: Bupivacaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT04814537?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04814537 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04814537's enrollment target sits among peer trials
100 7th of 19 higher than 10 of 19 other Analgesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Analgesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
TAP-patients With Robotic Assisted Lap Prostatectomy
COMPLETED · Phase 4
-
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI